Comparative Effects between Bone Marrow and Mesenchymal Stem Cell Transplantation in GDNF Expression and Motor Function Recovery in a Motorneuron Degenerative Mouse Model

Stem Cell Reviews and Reports

Volumn 8, Issue 2, 2012, Pages 445-458

  Pastor, Diego ^a   Viso León, Mari Carmen ^a   Jones, Jonathan ^a   Jaramillo Merchán, Jesus ^a   Toledo Aral, Juan José ^b   Moraleda, Jose M ^c   Martínez, Salvador ^a  

^a MIGUEL HERNÁNDEZ UNIVERSITY   (Spain)

^b HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^c HOSPITAL UNIVERSITARIO VIRGEN DE LA ARRIXACA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; GREEN FLUORESCENT PROTEIN;

ANIMAL; ANIMAL BEHAVIOR; APOPTOSIS; ARTICLE; BONE MARROW CELL; BONE MARROW TRANSPLANTATION; CELL CULTURE; CELL MOTION; CELL PROLIFERATION; CELL TRANSDIFFERENTIATION; COMPARATIVE STUDY; CONVALESCENCE; CYTOLOGY; DISEASE MODEL; IMMUNOHISTOCHEMISTRY; MESENCHYMAL STEM CELL; MESENCHYMAL STEM CELL TRANSPLANTATION; METABOLISM; MOTONEURON; MOTOR ACTIVITY; MOTOR NEURON DISEASE; MOUSE; MOUSE MUTANT; NUDE MOUSE; PATHOLOGY; PATHOPHYSIOLOGY; PHENOTYPE; PHYSIOLOGY; SPLEEN;

ANIMALS; APOPTOSIS; BEHAVIOR, ANIMAL; BONE MARROW CELLS; BONE MARROW TRANSPLANTATION; CELL MOVEMENT; CELL PROLIFERATION; CELL TRANSDIFFERENTIATION; CELLS, CULTURED; DISEASE MODELS, ANIMAL; GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR; GREEN FLUORESCENT PROTEINS; IMMUNOHISTOCHEMISTRY; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STEM CELLS; MICE; MICE, KNOCKOUT; MICE, NUDE; MOTOR ACTIVITY; MOTOR NEURON DISEASE; MOTOR NEURONS; PHENOTYPE; RECOVERY OF FUNCTION; SPLEEN;

ANIMALIA; MUS;

EID: 84861680252     PISSN: 15508943     EISSN: 15586804     Source Type: Journal    
DOI: 10.1007/s12015-011-9295-x     Document Type: Article

References (46)

1. Vucic, S., & Kiernan, M. C. (2006). Axonal excitability properties in amyotrophic lateral sclerosis. Clinical Neurophysiology, 117, 1458-1466.
2. Bruijn, L. I., Miller, T. M., & Cleveland, D. W. (2004). Unraveling the mechanisms involved in motor neuron degeneration in ALS. Annual Review of Neuroscience, 27, 723-749.
3. Rowland, L. P. (1998). Diagnosis of amyotrophic lateral sclerosis. Journal of Neurological Sciences, 160(Suppl 1), S6-S24.
4. Boillee, S., Yamanaka, K., Lobsiger, C. S., et al. (2006). Onset and progression in inherited ALS determined by motor neurons and microglia. Science, 312, 1389-1392.
5. Stavarachi, M., Apostol, P., Toma, M., Cimponeriu, D., & Gavrila, L. (2010). Spinal muscular atrophy disease: a literature review for therapeutic strategies. Journal of Medicine and Life, 3, 3-9.
6. Visser, J., van den Berg-Vos, R. M., Franssen, H., et al. (2007). Disease course and prognostic factors of progressive muscular atrophy. Archives of Neurology, 64, 522-528.
7. Lorson, C. L., Rindt, H., & Shababi, M. (2010). Spinal muscular atrophy: mechanisms and therapeutic strategies. Human Molecular Genetics, 19, R111-R118.
8. Silani, V., Cova, L., Corbo, M., Ciammola, A., & Polli, E. (2004). Stem-cell therapy for amyotrophic lateral sclerosis. Lancet, 364, 200-202.
9. Svendsen, C. N., & Langston, J. W. (2004). Stem cells for Parkinson disease and ALS: replacement or protection? Nature Medicine, 10, 224-225.
10. Mazzini, L., Fagioli, F., Boccaletti, R., et al. (2003). Stem cell therapy in amyotrophic lateral sclerosis: a methodological approach in humans. Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders, 4, 158-161.
11. Corti, S., Locatelli, F., Donadoni, C., et al. (2004). Wild-type bone marrow cells ameliorate the phenotype of SOD1-G93A ALS mice and contribute to CNS, heart and skeletal muscle tissues. Brain, 127, 2518-2532.
12. Cabanes, C., Bonilla, S., Tabares, L., & Martinez, S. (2007). Neuroprotective effect of adult hematopoietic stem cells in a mouse model of motoneuron degeneration. Neurobiology of Disease, 26, 408-418.
13. Kastin, A. J., Akerstrom, V., & Pan, W. (2003). Glial cell line-derived neurotrophic factor does not enter normal mouse brain. Neuroscience Letters, 340, 239-241.
14. Corti, S., Locatelli, F., Papadimitriou, D., Strazzer, S., & Comi, G. P. (2004). Somatic stem cell research for neural repair: current evidence and emerging perspectives. Journal of Cellular and Molecular Medicine, 8, 329-337.
15. Vercelli, A., Mereuta, O. M., Garbossa, D., et al. (2008). Human mesenchymal stem cell transplantation extends survival, improves motor performance and decreases neuroinflammation in mouse model of amyotrophic lateral sclerosis. Neurobiology of Disease, 31, 395-405.
16. Blot, S., Poirier, C., & Dreyfus, P. A. (1995). The mouse mutation muscle deficient (mdf) is characterized by a progressive motoneuron disease. Journal of Neuropathology and Experimental Neurology, 54, 812-825.
17. Poirier, C., Blot, S., Fernandes, M., et al. (1998). A high-resolution genetic map of mouse chromosome 19 encompassing the muscle-deficient osteochondrodystrophy (mdf-ocd) region. Mammalian Genome, 9, 390-391.
18. Schmidt, W. M., Kraus, C., Hoger, H., et al. (2007). Mutation in the Scyl1 gene encoding amino-terminal kinase-like protein causes a recessive form of spinocerebellar neurodegeneration. EMBO Reports, 8, 691-697.
19. Okabe, M., Ikawa, M., Kominami, K., Nakanishi, T., & Nishimune, Y. (1997). 'Green mice' as a source of ubiquitous green cells. FEBS Letters, 407, 313-319.
20. Sanchez, M. P., Silos-Santiago, I., Frisen, J., He, B., Lira, S. A., & Barbacid, M. (1996). Renal agenesis and the absence of enteric neurons in mice lacking GDNF. Nature, 382, 70-73.
21. Jones, J., Jaramillo-Merchan, J., Bueno, C., Pastor, D., Viso-Leon, M., & Martinez, S. (2010). Mesenchymal stem cells rescue Purkinje cells and improve motor functions in a mouse model of cerebellar ataxia. Neurobiology of Disease, 40, 415-423.
22. McGavern, D. B., Zoecklein, L., Drescher, K. M., & Rodriguez, M. (1999). Quantitative assessment of neurologic deficits in a chronic progressive murine model of CNS demyelination. Experimental Neurology, 158, 171-181.
23. Kaspar, B. K., Frost, L. M., Christian, L., Umapathi, P., & Gage, F. H. (2005). Synergy of insulin-like growth factor-1 and exercise in amyotrophic lateral sclerosis. Annals of Neurology, 57, 649-655.
24. Kayatekin, B. M., Gonenc, S., Acikgoz, O., Uysal, N., & Dayi, A. (2002). Effects of sprint exercise on oxidative stress in skeletal muscle and liver. European Journal of Applied Physiology, 87, 141-144.
25. He, Q., Wan, C., & Li, G. (2007). Concise review: multipotent mesenchymal stromal cells in blood. Stem Cells, 25, 69-77.
26. Herzog, E. L., Chai, L., & Krause, D. S. (2003). Plasticity of marrow-derived stem cells. Blood, 102, 3483-3493.
27. Giordano, A., Galderisi, U., & Marino, I. R. (2007). From the laboratory bench to the patient's bedside: an update on clinical trials with mesenchymal stem cells. Journal of Cellular Physiology, 211, 27-35.
28. Vitry, S., Bertrand, J. Y., Cumano, A., & Dubois-Dalcq, M. (2003). Primordial hematopoietic stem cells generate microglia but not myelin-forming cells in a neural environment. Journal of Neuroscience, 23, 10724-10731.
29. Alvarez-Dolado, M., Pardal, R., Garcia-Verdugo, J. M., et al. (2003). Fusion of bone-marrow-derived cells with Purkinje neurons, cardiomyocytes and hepatocytes. Nature, 425, 968-973.
30. Corti, S., Locatelli, F., Donadoni, C., et al. (2002). Neuroectodermal and microglial differentiation of bone marrow cells in the mouse spinal cord and sensory ganglia. Journal of Neuroscience Research, 70, 721-733.
31. Javazon, E. H., Beggs, K. J., & Flake, A. W. (2004). Mesenchymal stem cells: paradoxes of passaging. Experimental Hematology, 32, 414-425.
32. Hall, E. D., Oostveen, J. A., & Gurney, M. E. (1998). Relationship of microglial and astrocytic activation to disease onset and progression in a transgenic model of familial ALS. Glia, 23, 249-256.
33. Howland, D. S., Liu, J., She, Y., et al. (2002). Focal loss of the glutamate transporter EAAT2 in a transgenic rat model of SOD1 mutant-mediated amyotrophic lateral sclerosis (ALS). Proceedings of the National Academy of Sciences of the United States of America, 99, 1604-1609.
34. Zhao, C. P., Zhang, C., Zhou, S. N., et al. (2007). Human mesenchymal stromal cells ameliorate the phenotype of SOD1-G93A ALS mice. Cytotherapy, 9, 414-426.
35. Caplan, A. I., & Dennis, J. E. (2006). Mesenchymal stem cells as trophic mediators. Journal of Cellular Biochemistry, 98, 1076-1084.
36. Auffray, I., Chevalier, S., Froger, J., et al. (1996). Nerve growth factor is involved in the supportive effect by bone marrow-derived stromal cells of the factor-dependent human cell line UT-7. Blood, 88, 1608-1618.
37. Labouyrie, E., Dubus, P., Groppi, A., et al. (1999). Expression of neurotrophins and their receptors in human bone marrow. American Journal of Pathology, 154, 405-415.
38. Chen, X., Katakowski, M., Li, Y., et al. (2002). Human bone marrow stromal cell cultures conditioned by traumatic brain tissue extracts: growth factor production. Journal of Neuroscience Research, 69, 687-691.
39. Crigler, L., Robey, R. C., Asawachaicharn, A., Gaupp, D., & Phinney, D. G. (2006). Human mesenchymal stem cell subpopulations express a variety of neuro-regulatory molecules and promote neuronal cell survival and neuritogenesis. Experimental Neurology, 198, 54-64.
40. Araki, T., & Milbrandt, J. (2000). Ninjurin2, a novel homophilic adhesion molecule, is expressed in mature sensory and enteric neurons and promotes neurite outgrowth. Journal of Neuroscience, 20, 187-195.
41. Garcia, R., Aguiar, J., Alberti, E., de la Cuetara, K., & Pavon, N. (2004). Bone marrow stromal cells produce nerve growth factor and glial cell line-derived neurotrophic factors. Biochemical and Biophysical Research Communications, 316, 753-754.
42. Nagano, I., Shiote, M., Murakami, T., et al. (2005). Beneficial effects of intrathecal IGF-1 administration in patients with amyotrophic lateral sclerosis. Neurological Research, 27, 768-772.
43. Storkebaum, E., Lambrechts, D., Dewerchin, M., et al. (2005). Treatment of motoneuron degeneration by intracerebroventricular delivery of VEGF in a rat model of ALS. Nature Neuroscience, 8, 85-92.
44. Wang, Y., Mao, X. O., Xie, L., et al. (2007). Vascular endothelial growth factor overexpression delays neurodegeneration and prolongs survival in amyotrophic lateral sclerosis mice. Journal of Neuroscience, 27, 304-307.
45. Blanquer, M., Perez Espejo, M. A., Iniesta, F., et al. (2010). Bone marrow stem cell transplantation in amyotrophic lateral sclerosis: technical aspects and preliminary results from a clinical trial. Methods and Findings in Experimental and Clinical Pharmacology, 32(Suppl A), 31-37.
46. Suzuki, M., McHugh, J., Tork, C., et al. (2007). GDNF secreting human neural progenitor cells protect dying motor neurons, but not their projection to muscle, in a rat model of familial ALS. PloS One, 2, e689.